US Stock MarketDetailed Quotes

NVNO enVVeno Medical

Watchlist
  • 4.620
  • -0.160-3.35%
Close Apr 19 16:00 ET
  • 4.790
  • +0.170+3.68%
Post 19:50 ET
61.52MMarket Cap-2418P/E (TTM)

enVVeno Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1.23%25.24M
-2.82%6.28M
-13.04%5.35M
-2.46%6.81M
27.40%6.8M
47.59%24.93M
-28.17%6.46M
127.23%6.15M
192.79%6.99M
89.99%5.34M
Selling and administrative expenses
-22.39%11.66M
-9.99%3.3M
-30.28%2.55M
-33.55%2.6M
-15.36%3.2M
34.51%15.02M
-49.20%3.66M
146.90%3.66M
201.93%3.91M
221.68%3.78M
Research and development costs
37.01%13.58M
6.58%2.98M
12.28%2.8M
37.13%4.21M
131.64%3.6M
73.08%9.91M
56.96%2.8M
103.43%2.49M
181.93%3.07M
-4.90%1.55M
Operating profit
-1.23%-25.24M
2.82%-6.28M
13.04%-5.35M
2.46%-6.81M
-27.40%-6.8M
-47.59%-24.93M
28.17%-6.46M
-127.23%-6.15M
-192.79%-6.99M
-89.99%-5.34M
Net non-operating interest income expense
11.80%180K
18.18%52K
-41.33%44K
5.41%39K
800.00%45K
747.37%161K
780.00%44K
1,400.00%75K
428.57%37K
66.67%5K
Non-operating interest income
11.80%180K
18.18%52K
-41.33%44K
5.41%39K
800.00%45K
747.37%161K
780.00%44K
1,400.00%75K
--37K
66.67%5K
Other net income (expense)
1,411.76%1.54M
144.49%577K
1,547.62%304K
366.37%301K
360K
-70.52%102K
236K
-106.71%-21K
-11,400.00%-113K
Gain on sale of security
1,411.76%1.54M
144.49%577K
1,547.62%304K
366.37%301K
--360K
--102K
--236K
---21K
---113K
----
Income before tax
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
-92.21%-5.33M
Income tax
Net income
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
-92.21%-5.33M
Net income continuous Operations
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
-92.21%-5.33M
Minority interest income
Net income attributable to the parent company
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
-92.21%-5.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
-92.21%-5.33M
Basic earnings per share
13.18%-1.91
41.82%-0.32
16.67%-0.45
7.94%-0.58
-21.28%-0.57
-15.79%-2.2
41.49%-0.55
-107.69%-0.54
-125.00%-0.63
2.08%-0.47
Diluted earnings per share
13.18%-1.91
41.82%-0.32
16.67%-0.45
7.94%-0.58
-21.28%-0.57
-15.79%-2.2
41.49%-0.55
-107.69%-0.54
-125.00%-0.63
2.08%-0.47
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 1.23%25.24M-2.82%6.28M-13.04%5.35M-2.46%6.81M27.40%6.8M47.59%24.93M-28.17%6.46M127.23%6.15M192.79%6.99M89.99%5.34M
Selling and administrative expenses -22.39%11.66M-9.99%3.3M-30.28%2.55M-33.55%2.6M-15.36%3.2M34.51%15.02M-49.20%3.66M146.90%3.66M201.93%3.91M221.68%3.78M
Research and development costs 37.01%13.58M6.58%2.98M12.28%2.8M37.13%4.21M131.64%3.6M73.08%9.91M56.96%2.8M103.43%2.49M181.93%3.07M-4.90%1.55M
Operating profit -1.23%-25.24M2.82%-6.28M13.04%-5.35M2.46%-6.81M-27.40%-6.8M-47.59%-24.93M28.17%-6.46M-127.23%-6.15M-192.79%-6.99M-89.99%-5.34M
Net non-operating interest income expense 11.80%180K18.18%52K-41.33%44K5.41%39K800.00%45K747.37%161K780.00%44K1,400.00%75K428.57%37K66.67%5K
Non-operating interest income 11.80%180K18.18%52K-41.33%44K5.41%39K800.00%45K747.37%161K780.00%44K1,400.00%75K--37K66.67%5K
Other net income (expense) 1,411.76%1.54M144.49%577K1,547.62%304K366.37%301K360K-70.52%102K236K-106.71%-21K-11,400.00%-113K
Gain on sale of security 1,411.76%1.54M144.49%577K1,547.62%304K366.37%301K--360K--102K--236K---21K---113K----
Income before tax 4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M-92.21%-5.33M
Income tax
Net income 4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M-92.21%-5.33M
Net income continuous Operations 4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M-92.21%-5.33M
Minority interest income
Net income attributable to the parent company 4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M-92.21%-5.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M-92.21%-5.33M
Basic earnings per share 13.18%-1.9141.82%-0.3216.67%-0.457.94%-0.58-21.28%-0.57-15.79%-2.241.49%-0.55-107.69%-0.54-125.00%-0.632.08%-0.47
Diluted earnings per share 13.18%-1.9141.82%-0.3216.67%-0.457.94%-0.58-21.28%-0.57-15.79%-2.241.49%-0.55-107.69%-0.54-125.00%-0.632.08%-0.47
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg